Application of Cell-Free DNA Barcode-Enabled Single-Molecule Test for Non-Invasive Prenatal Testing of α-Thalassemia and β-Thalassemia. [PDF]
Liu Q +7 more
europepmc +1 more source
A machine-learning capillary electrophoresis-based pattern to identify suspected sickle cell trait and α-thalassemia co-inheritance. [PDF]
Ceacero-Marín D +4 more
europepmc +1 more source
Genetic profiles and hematological characteristics of the α-Hb variant Hb Chumphae (HBA2:c.32T>A) in association with -<sup>SEA</sup> deletion α<sup>0</sup>-thalassemia. [PDF]
Sihathip P +5 more
europepmc +1 more source
The value of third-generation sequencing for neonatal screening of thalassemia in the Yulin region of Southern China. [PDF]
Ning S +9 more
europepmc +1 more source
Prenatal diagnosis of hemoglobinopathies by chorionic villus sampling: A large single-center experience. [PDF]
Aykut S +5 more
europepmc +1 more source
A Culturally Embedded and Family-Oriented Approach to Thalassemia Prevention through Multisectoral Community Nursing Collaboration. [PDF]
Setiawan H +2 more
europepmc +1 more source
Related searches:
Management and control of hemoglobinopathies are a challenge in India where 67.0% of people reside in rural regions. The GDP spent on health is one of the lowest (1.3%) resulting in high out-of-pocket expenses. The β-thalassemias are prevalent with an estimated 7500-12000 new births each year. Hb S (HBB: c.20A>T) and Hb E (HBB: c.79G>A) are also common
Roshan B, Colah, Tulika, Seth
openaire +2 more sources
Abstract New developments in the epidemiology, treatment and prognosis of thalassemia have dramatically altered the approach to the care of affected patients, and these developments are likely to have an even greater impact in the next few years.
Alan R, Cohen +4 more
openaire +2 more sources
Beta-thalassemias are a group of hereditary blood disorders characterized by anomalies in the synthesis of the beta chains of hemoglobin resulting in variable phenotypes ranging from severe anemia to clinically asymptomatic individuals. The total annual incidence of symptomatic individuals is estimated at 1 in 100,000 throughout the world and 1 in 10 ...
Galanello R, ORIGA, RAFFAELLA
exaly +5 more sources
The thalassemia syndromes are hemoglobin disorders that result from significantly reduced or absent synthesis of either the α- or β-globin chains. The result is a chronic hemolytic anemia with ineffective erythropoiesis and bone marrow overstimulation.
Alissa, Martin, Alexis A, Thompson
openaire +2 more sources

